Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pfizer
(NY:
PFE
)
26.29
+0.02 (+0.10%)
Streaming Delayed Price
Updated: 3:32 PM EDT, Apr 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Pfizer
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Pfizer Seeks Expanded Use Of Abrysvo As Vaccine Shows Potential In 18+ Patients
April 09, 2024
Discover pivotal Phase 3 trial results for Pfizer's Abrysvo vaccine in adults 18-59 at risk of severe RSV disease. Achieved immunogenicity and safety milestones pave the way for potential regulatory...
Via
Benzinga
Decoding Pfizer's Options Activity: What's the Big Picture?
April 09, 2024
Via
Benzinga
How's AT&T Handling Things?
April 09, 2024
We've also got a look at 3M's spinoff, gold prices, and the beef industry.
Via
The Motley Fool
2 Ultra-High-Yield Dividend Stocks to Buy and Hold Forever
April 09, 2024
A rate cut would likely be a boon for these two ultra-high yield dividend stocks.
Via
The Motley Fool
Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.
April 09, 2024
These companies are close to launching new products that could supercharge revenue.
Via
The Motley Fool
3 Dirt-Cheap Stocks That Could Make You Filthy Rich
April 09, 2024
Cheap stocks offer a silver lining as the Fed takes a cautious stance, presenting opportunities for savvy investors.
Via
InvestorPlace
Topics
Economy
Exposures
Interest Rates
Billionaire Ken Griffin Loaded Up on This High-Yield Dividend Stock. Should You?
April 09, 2024
The current status of this stock might seem bleak. But like a chess grandmaster, Griffin is looking several moves ahead.
Via
The Motley Fool
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
April 09, 2024
These stocks, a bargain today, are players to hold on to for the long term.
Via
The Motley Fool
Why Is Ocugen (OCGN) Stock Up 7% Today?
April 08, 2024
Ocugen is returning to its eye treatment roots after a brief life as a Covid-19 vaccine meme stock in 2021 delivered OCGN stock no results.
Via
InvestorPlace
Exposures
COVID-19
Amazon, Alphabet And A Pharmaceutical Giant: CNBC's 'Final Trades'
April 08, 2024
On CNBC’s "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners said Amazon.com, Inc. (NASDAQ: AMZN) is on the
Via
Benzinga
The 3 Most Undervalued Healthcare Stocks to Buy in April 2024
April 08, 2024
Value investors looking for a deal should checkout these healthcare companies, each of which has a stock that looks undervalued.
Via
InvestorPlace
This S&P 500 Dividend Stock Could Be the Best Bad-News Buy on the Market
April 08, 2024
There could be a light at the end of the tunnel for this beaten-down stock.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Forget Nvidia: 3 Prominent Billionaire Investors Are Selling It and Buying These 6 Value Stocks Instead
April 08, 2024
Three highly successful billionaire money managers are paring down their respective stakes in artificial intelligence (AI) titan Nvidia and purchasing shares of six beaten-down value stocks.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
My Top-5 Ultrahigh-Yield Dividend Stocks to Buy in April
April 07, 2024
Let April showers rain down dividends on you with these great stocks.
Via
The Motley Fool
3 No-Brainer Dividend Stocks to Buy in April
April 06, 2024
Income investors will find a lot to like about these stocks.
Via
The Motley Fool
Got $1,000? 2 Phenomenal Growth Stocks to Buy in 2024 and Hold at Least a Decade
April 06, 2024
These stocks have unique buying propositions for long-term investors.
Via
The Motley Fool
The 7 Most Undervalued Russell 2000 Stocks to Buy in April 2024
April 05, 2024
With risk-on sentiment in place, investors may be looking for the most undervalued Russell 2000 stocks to buy in April.
Via
InvestorPlace
3 Healthcare Stocks Short Sellers Are Prescribing for Trouble
April 05, 2024
The healthcare industry is one of the most potent yet also one of the most competitive. This has short sellers out for blood.
Via
InvestorPlace
Redditors Discuss What The Top 3 Value Stock Picks Are Right Now
April 05, 2024
Uncovering value amidst market fluctuations is a quest pursued by many investors. Reddit's r/ValueInvesting community shares insights on top 3 value picks: TSMC, Pfizer, and Berkshire Hathaway.
Via
Benzinga
The 3 Most Undervalued Biotech Stocks to Buy in April 2024
April 05, 2024
The most undervalued biotech stocks to buy in April are intriguing value options with mature biotech plays that boast impressive pipelines.
Via
InvestorPlace
Pfizer's Paxlovid Demonstrates Safety But Raises Questions on Efficacy in Low-Risk Covid-19 Patients-NEJM Study
April 05, 2024
New England Journal of Medicine publishes Pfizer's Paxlovid trial data, revealing insights into COVID-19 treatment efficacy, hospitalization rates, and adverse events. Learn more about the study's...
Via
Benzinga
Exposures
COVID-19
3 High-Yield Dividend Stocks to Buy Now for a Lifetime of Passive Income
April 05, 2024
These stocks could outperform the broad market while they deliver heaps of dividend income.
Via
The Motley Fool
The Comeback Kids: 7 Stocks Ready to Rise from the Ashes
April 04, 2024
Discover seven resilient comeback stocks thriving across diverse sectors, from pharma to tech, poised for growth amid economic flux.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
April 04, 2024
Via
Benzinga
In Heart Burn Drug Zantac's Litigation Saga, Sanofi Nears Settlement in Major Lawsuit Cluster
April 04, 2024
Sanofi reaches a settlement in principle for about 4,000 Zantac lawsuits in the US, excluding Delaware, regarding alleged cancer risks linked to NDMA. Financial terms remain undisclosed.
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
AstraZeneca CEO Highlights Decade-Long Sales Goal Of $45B Along With Investor Doubts As It Lags In Weight Loss Race
April 02, 2024
AstraZeneca's CEO Pascal Soriot celebrates hitting a $45 billion sales target set a decade ago despite initial skepticism. Investor confidence remains a challenge amid stagnant shares and concerns over...
Via
Benzinga
Merger Mania: 3 Potential Takeover Targets to Watch for Lucrative Buyouts
April 02, 2024
With interest rates poised to fall, acquisitions will become more numerous. Here are three potential takeover targets.
Via
InvestorPlace
Pharma's Post-Pandemic Story To Unlock A Cancer-Free Era
April 02, 2024
Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) did not only earn billions of dollars from their COVID-19 leading products but also rose to fame for saving the world from an unforeseen pandemic.
Via
Benzinga
Exposures
COVID-19
4 Stocks High on My Watchlist to Buy
April 02, 2024
4 high-quality stocks that need to pullback a bit
Via
The Motley Fool
3 Magnificent Ultra-High-Yield Dividend Stocks That Are Screamings Buys in April
April 02, 2024
These supercharged dividend stocks -- sporting an average yield of 9.02% -- can pack a punch for income investors' pocketbooks.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.